Search

Author/Creator Carreira, S

1. 838PPI3K/AKT pathway deleterious mutations in lethal prostate cancer. (23rd October 2018)

Authors:
Rescigno, P; Rediti, M; Dolling, D; Rodrigues, D N; Bianchini, D; Riisnaes, R; Messina, C; Barrero, M; Petremolo, A; Sharp, A; Sumanasuriya, S; Seed, G; Figueiredo, I; Miranda, S; Goodall, J; Mateo, J; Chandler, R; Yuan, W; Carreira, S; de Bono, J S
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Testing strategies for the safety of nanoparticles used in medical applications. (August 2009)

Authors:
Dusinska, Maria; Dusinska, M; Fjellsbøø, LM; Magdolenova, Z; Rinna, A; Runden Pran, E; Bartonova, A; Heimstad, ES; Harju, M; Tran, L; Ross, B; Juillerat, L; Halamoda Kenzaui, B; Marano, F; Boland, S; Guadaginini, R; Saunders, M; Cartwright, L; Carreira, S; Whelan, M
Journal:
Nanomedicine
Issue:
Volume 4:Number 6(2009)
Page Start:
605
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Vistusertib (dual m-TORC1/2 inhibitor) in combination with paclitaxel in patients with high-grade serous ovarian and squamous non-small-cell lung cancer. (17th July 2018)

Authors:
Basu, B; Krebs, M G; Sundar, R; Wilson, R H; Spicer, J; Jones, R; Brada, M; Talbot, D C; Steele, N; Ingles Garces, A H; Brugger, W; Harrington, E A; Evans, J; Hall, E; Tovey, H; de Oliveira, F M; Carreira, S; Swales, K; Ruddle, R; Raynaud, F I
Journal:
Annals of oncology
Issue:
Volume 29:Number 9(2018)
Page Start:
1918
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗